Résumé
Les objectifs de cette recherche sont de (1) présenter l’adaptation française du Patient Generated Index (PGI, [17]), (2) tester ses qualités psychométriques et (3) d’examiner les limites pratiques de cet outil. Pour ce faire, deux études ont été conduites. La première est une étude qualitative avec 18 participants qui ont indiqué leurs difficultés et leurs commentaires pour compléter la première traduction à rebours du questionnaire. La seconde étude teste les qualités psychométriques de la version française adaptée et révisée du PGI sur 97 patients traités pour un cancer. Pour tester la validité de critère de l’outil, ils ont aussi rempli le Quality of Life Questionnaire C30 (QLQ-C30), le Profile Of Mood States (POMS) et le Satisfaction With Life Scale (SWLS). Au regard des résultats, le PGI présente une bonne sensibilité et validité. Néanmoins une stabilité test-retest semble être à améliorer.
Abstract
The aims of this research are to (1) present the French version of the Patient Generated Index (PGI, [17]), (2) test its psychometric characteristics and (3) examine the tool’s practical limitations. To achieve those goals, we conducted two studies. The first was a qualitative study of 18 participants who indicated their difficulties and expressed other comments concerning the completion of an initial back translation of the PGI. The second study tested the psychometric qualities of the adapted and revised back translation of the PGI with 97 cancer patients. To assess criterion validity, they also completed the Quality of Life Questionnaire C30 (QLQ-C30), Profile of Mood States (POMS) and Satisfaction With Life Scale (SWLS). The results indicate that PGI has good sensitivity, validity and test-retest stability. Test-retest reliability, nevertheless, must be improved.
This is a preview of subscription content, log in via an institution to check access.
Références
Aaronson NK, Ahmedzai S, Bergman B, et al. (1993) The European-Organisation for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85: 365–376
Camilleri-Brennan J, Ruta D, Steele R (2002) Patient Generated Index: new instrument for measuring quality of life in patients with rectal cancer. World J Surg 26: 1354–1359
Carr A, Higginson I (2001) Are quality of life measures patient centred? BMJ 322(7298): 1357–1360
Cayrou S, Dickes P, Gauvain-Piquard A, et al. (2000) Validation de la traduction française du POMS (Profile Of Mood States). Psychologie et Psychométrie 21: 5–22
Detmar S, Muller M, Schornagel J, et al. (2002) Role of health-related quality of life in palliative chemotherapy treatment decisions. J Clin Oncol 15: 1056–1062
Diener E, Emmons R, Larsen R, et al. (1985) The Satisfaction With Life Scale. J Pers Assess 49: 71–75
Frick E, Borasio G, Zehentner H, et al. (2003) Individual quality of life of patients undergoing autologous peripheral blood stem cell transplantation. Psycho-Oncology 13: 116–124
Leplege A, Ecosse E, Pouchot J, et al. (1998) The French SF-36 Health Survey: translation, cultural adaptation and preliminary psychometric evaluation. J Clin Epidemiol 51: 1013–1023
Llewellyn C, McGurk M, Weinman J (2006) Head and neck cancer: To what extent can psychological factors explain differences between health-related quality of life and individual quality of life? Br J Oral Maxillofac Surg 44(5): 351–357
Macduff C, Russell E (1998) The problem of measuring change in individual health-related quality of life by postal questionnaire: use of the Patient Generated Index in a disabled population. Qual Life Res 7: 761–769
McGee H, O’Boyle C, Hickey A, et al. (1991) Assessing the quality of life of the individual: the SEiQoL with a healthy and a gastroenterology unit population. Psychol Med 21: 749–759
McNair D, Lorr M, Droppleman L (1971, 1981, 1992) EdITS Manuel for the Profile Of Mood States, San Diego. CA: Educational and industrial Testing Service
Osoba D (2002) A taxonomy of the uses of health-related quality-of-life instruments in cancer care and the clinical meaningfulness of the results. Med Care 40: 54–55
Patel K, Veenstra D, Patrick D (2003) A review of selected patient generated outcome measures and their application in clinical trials. Value Health 6: 595–603
Rodary C, Dauchy S, Beauvallet C, et al. (2005) Intérêt de la mesure individualisée de la qualité de vie en oncologie: utilisation du SEIQoL chez des patients traités pour une tumeur neuro-endocrine. Rev Francoph Psycho-Oncologie 1: 36–44
Rodary C, Ruffié P, Baudin E (2001) 2nd phase of validation of the Schedule for the Evaluation of Individual Quality of Life (SEIQoL) in advanced cancer. Eur J Cancer 37(supp 2): S.89
Ruta D, Garratt A, Russel I (1999) Patient centred assessment of quality of life for patients with four common conditions. Qual Health Care 8: 22–29
Velikova G, Booth L, Smith A, et al. (2004) Measuring quality of life in routine oncology practice improves communication and patient well-being: a randomized controlled trial. J Clin Oncol 22: 714–724
Ware J, Sherbourne C (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30: 473–483
Author information
Authors and Affiliations
Corresponding authors
Additional information
Nous tenons à remercier le professeur Todd Lubart pour sa participation à la traduction à rebours du questionnaire.
About this article
Cite this article
Botella, M., Zenasni, F., Pocard, M. et al. Adaptation française du Patient Generated Index: qualités métrologiques et limites pratiques. Psycho Oncologie 1, 131–140 (2007). https://doi.org/10.1007/s11839-007-0016-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11839-007-0016-2